What is the prevalence of Pure Red Cell Aplasia?

Pure Red Cell Aplasia (PRCA) is a rare hematologic disorder characterized by a severe reduction in red blood cell precursors in the bone marrow, leading to profound anemia. While exact global prevalence is difficult to determine due to its rarity and secondary causes, it is considered an ultra-rare condition, with many cases remaining underdiagnosed or misclassified within broader anemias.

Is Pure Red Cell Aplasia considered rare or common?

Pure Red Cell Aplasia is classified as a rare disease. Because it often occurs secondary to other conditions—such as thymoma, autoimmune disorders, or viral infections—the true incidence is challenging to pinpoint. According to Orphanet, primary acquired Pure Red Cell Aplasia is estimated to affect approximately 1 in 1,000,000 individuals, though this figure likely underestimates the total patient population due to diagnostic limitations.

What are the demographic patterns of Pure Red Cell Aplasia?

The presentation of Pure Red Cell Aplasia varies significantly by type:

• Age of Onset: Congenital forms (Diamond-Blackfan anemia) typically appear in infancy, while acquired Pure Red Cell Aplasia is more common in adults, often between the ages of 40 and 60.


• Gender Distribution: Acquired forms show a relatively equal distribution between males and females, though specific secondary triggers may skew these ratios.


• Geographic/Ethnic Variations: There is no clear evidence of geographic or ethnic clusters, suggesting Pure Red Cell Aplasia occurs globally across diverse populations.

Why is accurate data on Pure Red Cell Aplasia difficult to obtain?

The primary challenge in mapping the prevalence of Pure Red Cell Aplasia is the high rate of misdiagnosis. Many patients are treated for generalized anemia before a bone marrow biopsy confirms the specific absence of erythroblasts. At DiseaseMaps.org, 10 community members have shared their experiences with Pure Red Cell Aplasia, providing vital, real-world data that helps bridge the gap between clinical literature and the lived patient experience.

Next steps

• Consult a hematologist for a definitive bone marrow biopsy and diagnostic workup.


• Join the DiseaseMaps.org community to connect with other individuals living with Pure Red Cell Aplasia.


• Discuss potential underlying triggers, such as thymoma or parvovirus B19, with your specialist.


• Monitor your hemoglobin levels regularly as advised by your clinical team.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet: Acquired pure red cell aplasia (ORPHA:776)


• NIH Genetic and Rare Diseases Information Center (GARD): Pure red cell aplasia


• OMIM (Online Mendelian Inheritance in Man): Entry #205900 (Diamond-Blackfan Anemia)


• Blood Journal (ASH): Clinical reviews on the pathophysiology of red cell aplasia